HomeREVB • NASDAQ
add
Revelation Biosciences Inc
Previous close
$1.00
Day range
$1.00 - $1.09
Year range
$0.83 - $60.48
Market cap
6.13M USD
Avg Volume
113.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.94M | 8.14% |
Net income | -1.91M | 14.92% |
Net profit margin | — | — |
Earnings per share | -1.77 | 95.61% |
EBITDA | -1.94M | -8.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.71M | 94.29% |
Total assets | 12.86M | 90.74% |
Total liabilities | 1.85M | -54.40% |
Total equity | 11.00M | — |
Shares outstanding | 5.92M | — |
Price to book | 0.33 | — |
Return on assets | -53.23% | — |
Return on capital | -65.52% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.91M | 14.92% |
Cash from operations | -1.59M | 82.84% |
Cash from investing | — | — |
Cash from financing | 9.12M | 143.77% |
Net change in cash | 7.53M | 236.20% |
Free cash flow | -859.43K | 89.46% |
About
Founded
2019
Website
Employees
8
